CoChat
Sign Up
Cited by 31HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and OutcomesHomelessness and Social Issues

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Impact of safe consumption facilities on individual and community outcomes: A scoping review of the past decade of research

Open access
Dow-Fleisner, Sarah J., Lomness, Arielle, Woolgar, Lucía·2022·Emerging Trends in Drugs, Addictions, and Health
DOI 10.1016/j.etdah.2022.100046
Open this paper in CoChat — free accountOpen PDF

Abstract

Globally, the rate of injection drug use has increased, leading to a rise in injection-related injuries, infections, disease transmission, and death. Safe consumption facilities (SCFs) were developed with the aim of reducing injection-related disease transmission and death. There is a rapidly growing body of literature related the individual and community level outcomes associated with SCFs that warrants a comprehensive review. Thus, this scoping review examined the impact and effectiveness of SCFs related to: 1) individual outcomes for people who inject drugs; 2) community outcomes associated with SCFs; and 3) the cost-effectiveness of SCFs. The search strategy, developed by the lead author and a social work librarian, followed the PRISMA scoping review extension guidelines. We searched eight databases for peer-reviewed qualitative and quantitative articles published in English over the past decade, returning a total of 1,255 articles. After screening, we extracted data from 24 articles. Findings indicate that SCFs were associated with reducing drug use related infection and disease transmission, enhancing access to addiction and other health services, reducing the risk of non-fatal overdoses, and were not associated with a significant increase in drug use, an increased rate of drug-related crime. Both qualitative and quantitative research support SCFs as a cost-effective approach to harm reduction for people who inject drugs with positive community outcomes as well. This review discusses the current state of the evidence and provides recommendations for future research directions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.etdah.2022.100046

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Andresen, 2010, A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility, Int. J. Drug Policy, 21, 70, 10.1016/j.drugpo.2009.03.004 · DOI
  2. Barry, 2019, Arguments supporting and opposing legalization of safe consumption sites in the US, Int. J. Drug Policy, 63, 18, 10.1016/j.drugpo.2018.10.008 · DOI
  3. Belackova, 2019, Drug consumption rooms: a systematic review of evaluation methodologies, Drug Alcohol Rev., 38, 406, 10.1111/dar.12919 · DOI
  4. Beletsky, 2018, The global health and equity imperative for safe consumption facilities, Lancet North Am. Ed., 392, 553, 10.1016/S0140-6736(18)31469-7 · DOI
  5. Bergamo, 2019, Harm reduction in Italy: the experience of an unsanctioned supervised injection facility run by drug users, Drugs Alcohol Today, 19, 59, 10.1108/DAT-03-2018-0011 · DOI
  6. Caulkins, 2019, Supervised consumption sites: a nuanced assessment of the causal evidence, Addiction, 114, 2109, 10.1111/add.14747 · DOI
  7. Colledge, 2019, The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis, Int. J. Drug Policy, 73, 172, 10.1016/j.drugpo.2019.07.030 · DOI
  8. Davidson, 2018, Using drugs in un/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States, Int. J. Drug Policy, 53, 37, 10.1016/j.drugpo.2017.12.005 · DOI
  9. DeBeck, 2011, Injection drug use cessation and use of North America's first medically supervised safer injecting facility, Drug Alcohol Depend., 113, 172, 10.1016/j.drugalcdep.2010.07.023 · DOI
  10. Degenhardt, 2017, Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review, Lancet Glob. Health, 5, e1192, 10.1016/S2214-109X(17)30375-3 · DOI
  11. Espelt, 2017, The impact of harm reduction programs and police interventions on the number of syringes collected from public spaces. A time series analysis in Barcelona, 2004–2014, Int. J. Drug Policy, 50, 11, 10.1016/j.drugpo.2017.07.033 · DOI
  12. Folch, 2018, Drug consumption rooms in Catalonia: a comprehensive evaluation of social, health and harm reduction benefits, Int. J. Drug Policy, 62, 24, 10.1016/j.drugpo.2018.09.008 · DOI
  13. Hullsiek, 2002, Propensity score modeling strategies for the causal analysis of observational data, Biostatistics, 3, 179, 10.1093/biostatistics/3.2.179 · DOI
  14. Irvine, 2019, Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic, Addiction, 114, 1602, 10.1111/add.14664 · DOI
  15. Jacka, 2020, Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada, Am. J. Public Health, 110, 45, 10.2105/AJPH.2019.305379 · DOI
  16. Jozaghi, 2013, Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?, Harm Reduct. J., 10, 1, 10.1186/1477-7517-10-1 · DOI
  17. Jozaghi, 2013, A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada, Subst. Abuse. Treat. Prev. Policy, 8, 1, 10.1186/1747-597X-8-25 · DOI
  18. Kennedy, 2017, Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review, Curr. HIV/AIDS Rep., 14, 161, 10.1007/s11904-017-0363-y · DOI
  19. Kennedy, 2019, Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: a cohort study, PLoS Med., 16, 10.1371/journal.pmed.1002964 · DOI
  20. Kennedy, 2019, Supervised injection facility utilization patterns: a prospective cohort study in Vancouver, Canada, Am. J. Prev. Med., 57, 330, 10.1016/j.amepre.2019.04.024 · DOI
  21. Kennedy, 2020, Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: a gender-based analysis, Int. J. Drug Policy, 78, 10.1016/j.drugpo.2020.102692 · DOI
  22. Kerman, 2020, “It's not just injecting drugs”: supervised consumption sites and the social determinants of health, Drug Alcohol Depend., 213, 10.1016/j.drugalcdep.2020.108078 · DOI
  23. Kerr, 2017, Supervised injection facilities in Canada: past, present, and future, Harm Reduct. J., 14, 28, 10.1186/s12954-017-0154-1 · DOI
  24. Kinnard, 2014, Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark, Harm Reduct. J., 11, 29, 10.1186/1477-7517-11-29 · DOI
  25. León, 2018, Changes in public order after the opening of an overdose monitoring facility for people who inject drugs, Int. J. Drug Policy, 53, 90, 10.1016/j.drugpo.2017.12.009 · DOI
  26. Levitt, 2020, Infectious diseases and injection drug sse: public health burden and response, J. Infect. Dis., 222, S213, 10.1093/infdis/jiaa432 · DOI
  27. Madah-Amiri, 2019, Ambulance-attended opioid overdoses: an examination into overdose locations and the role of a safe injection facility, Subst. Abus., 40, 383, 10.1080/08897077.2018.1485130 · DOI
  28. Magwood, 2020, The effectiveness of substance use interventions for homeless and vulnerably housed persons: a systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder, PLoS One, 15, 10.1371/journal.pone.0227298 · DOI
  29. Marshall, 2011, Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study, Lancet North Am. Ed., 377, 1429, 10.1016/S0140-6736(10)62353-7 · DOI
  30. McNeil, 2014, ‘Safer environment interventions’: a qualitative synthesis of the experiences and perceptions of people who inject drugs, Soc. Sci. Med., 106, 151, 10.1016/j.socscimed.2014.01.051 · DOI
  31. Olding, 2020, A low-barrier and comprehensive community-based harm-reduction site in Vancouver, Canada, Am. J. Public Health, 110, 833, 10.2105/AJPH.2020.305612 · DOI
  32. Pinkerton, 2010, Is Vancouver Canada's supervised injection facility cost-saving?, Addiction, 105, 1429, 10.1111/j.1360-0443.2010.02977.x · DOI
  33. Potier, 2014, Supervised injection services: what has been demonstrated? A systematic literature review, Drug Alcohol Depend., 145, 48, 10.1016/j.drugalcdep.2014.10.012 · DOI
  34. Rance, 2011, Accidental intimacy: transformative emotion and the Sydney medically supervised injecting centre, Contemp. Drug Probl., 38, 121, 10.1177/009145091103800106 · DOI
  35. Salmon, 2010, The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia, Addiction, 105, 676, 10.1111/j.1360-0443.2009.02837.x · DOI
  36. Scheim, 2020, Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada, Int. J. Drug Policy, 87
  37. Scherbaum, 2010, Longitudinal observation of a sample of German drug consumption facility clients, Subst. Use Misuse, 45, 176, 10.3109/10826080902873044 · DOI
  38. Small, 2012, Perceptions of risk and safety within injection settings: injection drug users' reasons for attending a supervised injecting facility in Vancouver, Canada, Health Risk Soc., 14, 307, 10.1080/13698575.2012.680950 · DOI

Cited by

Sorted by citations

See all 31

Metadata

Authors
Dow-Fleisner, S. J., Lomness, A., & Woolgar, L.
Affiliations
University of British Columbia, Okanagan Campus (CA)
ORCID
Venue
Emerging Trends in Drugs, Addictions, and Health
Publisher
Elsevier BV
Published
2022
Volume
2
Pages
100046
ISSN
2667-1182 (ISSN-L)
DOI
10.1016/j.etdah.2022.100046
OpenAlex
W4291733856
Cited by
31
References
1
Citations by year
2026: 9 · 2025: 14 · 2024: 8
FWCI
3.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Emerging Trends in Drugs Addictions and Health (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Sociology and Political Science › Homelessness and Social Issues
Keywords
harm reduction, people who inject drugs, intravenous drug use, drug-related infections, disease transmission, overdose risk, drug offenses, cost-effectiveness, community outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review